{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:14:09Z","timestamp":1790194449735,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32273008"],"award-info":[{"award-number":["32273008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis, especially drug-resistant tuberculosis remains a global threat, and new drugs are desperately needed to combat the spread of multidrug-resistant\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    . Here we describe a natural macrotetrolide dinactin with anti-tuberculosis activity against susceptive and non-replicating\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    . Dinactin can also synergistically enhance the anti-tuberculosis effect of rifampicin and isoniazid against drug-resistant strains.Furthermore, dinactin exhibited excellently antituberculosis effect in macrophage and\n                    <jats:italic>Galleria mellonella<\/jats:italic>\n                    models. Since the ionophore properties of dinactin, it not only enhanced cations transport and altered membrane permeability but also caused the dissipation of proton motive force and metabolic perturbations. Finally, through the selection of spontaneous resistant mutants and whole genome sequencing, non-synonymous single nucleotide polymorphisms were successfully identified in the\n                    <jats:italic>cpsA<\/jats:italic>\n                    gene of the LytR-Cps2A-Psr family. The dinactin-resistant mutants exhibited decreased in vitro drug sensitivity to dinactin without cross-resistance to first-line antituberculosis drugs. Genetic studies and molecular biology assays have subsequently confirmed\n                    <jats:italic>cpsA<\/jats:italic>\n                    as one of the potential targets for dinactin\u2019s anti-tuberculosis activity. Collectively, these data indicate that dinactin could be a promising candidate for treating tuberculosis.\n                  <\/jats:p>","DOI":"10.1038\/s42003-026-09654-3","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:48:13Z","timestamp":1770889693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Naturally occurring dinactin targets cpsA protein and kills Mycobacterium tuberculosis by disrupting the\u00a0proton motive force"],"prefix":"10.1038","volume":"9","author":[{"given":"Gaoyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-1378","authenticated-orcid":false,"given":"Xiangru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-4483","authenticated-orcid":false,"given":"Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"9654_CR1","unstructured":"WHO. Global Tuberculosis Report 2021 (World Health Organization, 2021)."},{"key":"9654_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrd4001","volume":"12","author":"A Zumla","year":"2013","unstructured":"Zumla, A., Nahid, P. & Cole, S. T. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov. 12, 388\u2013404 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9654_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1060028013504087","volume":"48","author":"EB Chahine","year":"2014","unstructured":"Chahine, E. B., Karaoui, L. R. & Mansour, H. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.  Ann. Pharmacother. 48, 107\u2013115 (2014).","journal-title":"Ann. Pharmacother."},{"key":"9654_CR4","doi-asserted-by":"crossref","unstructured":"British Thoracic Society. A controlled trial of 6 months\u2019 chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. Br. J. Dis. Chest 78, 330\u2013336 (1984).","DOI":"10.1016\/0007-0971(84)90165-7"},{"key":"9654_CR5","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1126\/science.aaa4690","volume":"348","author":"A Kling","year":"2015","unstructured":"Kling, A. et al. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science 348, 1106\u20131112 (2015).","journal-title":"Science"},{"key":"9654_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.drudis.2016.11.015","volume":"22","author":"M Dong","year":"2017","unstructured":"Dong, M., Pfeiffer, B. & Altmann, K. H. Recent developments in natural product-based drug discovery for tuberculosis. Drug Discov. Today 22, 585\u2013591 (2017).","journal-title":"Drug Discov. Today"},{"key":"9654_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nm.3458","volume":"20","author":"RE Lee","year":"2014","unstructured":"Lee, R. E. et al. Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux. Nat. Med. 20, 152\u2013158 (2014).","journal-title":"Nat. Med."},{"key":"9654_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14414","volume":"8","author":"AT Tran","year":"2017","unstructured":"Tran, A. T. et al. Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis. Nat. Commun. 8, 14414 (2017).","journal-title":"Nat. Commun."},{"key":"9654_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/emmm.201201689","volume":"4","author":"RC Hartkoorn","year":"2012","unstructured":"Hartkoorn, R. C. et al. Towards a new tuberculosis drug: pyridomycin - nature\u2019s isoniazid. EMBO Mol. Med. 4, 1032\u20131042 (2012).","journal-title":"EMBO Mol. Med."},{"key":"9654_CR10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1021\/cb300151m","volume":"7","author":"SA Stanley","year":"2012","unstructured":"Stanley, S. A. et al. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. ACS Chem. Biol. 7, 1377\u20131384 (2012).","journal-title":"ACS Chem. Biol."},{"key":"9654_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/emmm.201201772","volume":"6","author":"B Lechartier","year":"2014","unstructured":"Lechartier, B., Rybniker, J., Zumla, A. & Cole, S. T. Tuberculosis drug discovery in the post-post-genomic era. EMBO Mol. Med. 6, 158\u2013168 (2014).","journal-title":"EMBO Mol. Med."},{"key":"9654_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1106753","volume":"307","author":"K Andries","year":"2005","unstructured":"Andries, K. et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307, 223\u2013227 (2005).","journal-title":"Science"},{"key":"9654_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.1171583","volume":"324","author":"V Makarov","year":"2009","unstructured":"Makarov, V. et al. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324, 801\u2013804 (2009).","journal-title":"Science"},{"key":"9654_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrd.2017.111","volume":"16","author":"JG Moffat","year":"2017","unstructured":"Moffat, J. G., Vincent, F., Lee, J. A., Eder, J. & Prunotto, M. Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat. Rev. Drug Discov. 16, 531\u2013543 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9654_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/hlca.19620450227","volume":"45","author":"J Beck","year":"1962","unstructured":"Beck, J., Gerlach, H., Prelog, V. & Voser, W. Stoffwechselprodukte von Actinomyceten. 35. Mitteilung. \u00dcber die Konstitution der Makrotetrolide Monactin, Dinactin und Trinactin. Helvetica Chim. Acta 45, 620\u2013630 (1962).","journal-title":"Helvetica Chim. Acta"},{"key":"9654_CR16","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.procbio.2016.08.014","volume":"51","author":"H He","year":"2016","unstructured":"He, H. et al. A novel pH\u2013precursor\u2013glucose synergic control strategy for dinactin biosynthesis by an arctic actinomycete Streptomyces sp. Process Biochem. 51, 1911\u20131918 (2016).","journal-title":"Process Biochem."},{"key":"9654_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijantimicag.2018.09.019","volume":"53","author":"A Hussain","year":"2019","unstructured":"Hussain, A. et al. In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 53, 49\u201353 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"9654_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF02884062","volume":"36","author":"J Jizba","year":"1991","unstructured":"Jizba, J. et al. Macrotetrolide antibiotics produced by Streptomyces globisporus. Folia Microbiol.36, 437\u2013443 (1991).","journal-title":"Folia Microbiol."},{"key":"9654_CR19","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/bip.1975.360141107","volume":"14","author":"GDJ Phillies","year":"1975","unstructured":"Phillies, G. D. J., Asher, I. M. & Stanley, H. E. Nonactin, monactin, dinactin, trinactin, and tetranactin. A Raman spectroscopic study. Biopolymers 14, 2311\u20132327 (1975).","journal-title":"Biopolymers"},{"key":"9654_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF02815533","volume":"43","author":"Z Zizka","year":"1998","unstructured":"Zizka, Z. Biological effects of macrotetrolide antibiotics and nonactic acids. Folia Microbiol. 43, 7\u201314 (1998).","journal-title":"Folia Microbiol."},{"key":"9654_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","volume":"43","author":"JC Betts","year":"2002","unstructured":"Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A. & Duncan, K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43, 717\u2013731 (2002).","journal-title":"Mol. Microbiol."},{"key":"9654_CR22","first-page":"61","volume":"79","author":"B Blomberg","year":"2001","unstructured":"Blomberg, B., Spinaci, S., Fourie, B. & Laing, R. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bull. World Health Organ. 79, 61\u201368 (2001).","journal-title":"Bull. World Health Organ."},{"key":"9654_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.micro.55.1.139","volume":"55","author":"LG Wayne","year":"2001","unstructured":"Wayne, L. G. & Sohaskey, C. D. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55, 139\u2013163 (2001).","journal-title":"Annu. Rev. Microbiol."},{"key":"9654_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/BF01869788","volume":"1","author":"G Szabo","year":"1969","unstructured":"Szabo, G., Eisenman, G. & Ciani, S. The effects of the macrotetralide actin antibiotics on the electrical properties of phospholipid bilayer membranes.  J. Membr. Biol. 1, 346\u2013382 (1969).","journal-title":"J. Membr. Biol."},{"key":"9654_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0006-3495(82)84501-3","volume":"39","author":"JY Lapointe","year":"1982","unstructured":"Lapointe, J. Y. & Laprade, R. Kinetics of carrier-mediated ion transport in two new types of solvent-free lipid bilayers. Biophys. J. 39, 141\u2013150 (1982).","journal-title":"Biophys. J."},{"key":"9654_CR26","doi-asserted-by":"publisher","first-page":"17155","DOI":"10.1021\/ja9050235","volume":"131","author":"BR Kusche","year":"2009","unstructured":"Kusche, B. R., Smith, A. E., McGuirl, M. A. & Priestley, N. D. Alternating pattern of stereochemistry in the nonactin macrocycle is required for antibacterial activity and efficient ion binding. J. Am. Chem. Soc. 131, 17155\u201317165 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"9654_CR27","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1073\/pnas.1904700116","volume":"116","author":"W Kim","year":"2019","unstructured":"Kim, W. et al. A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 116, 16529\u201316534 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9654_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF00718783","volume":"5","author":"T Parasassi","year":"1995","unstructured":"Parasassi, T. & Gratton, E. Membrane lipid domains and dynamics as detected by Laurdan fluorescence. J. Fluoresc. 5, 59\u201369 (1995).","journal-title":"J. Fluoresc."},{"key":"9654_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1476-7","volume":"4","author":"S Halder","year":"2015","unstructured":"Halder, S. et al. Alteration of Zeta potential and membrane permeability in bacteria: a study with cationic agents. Springerplus 4, 672 (2015).","journal-title":"Springerplus"},{"key":"9654_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12393","volume":"7","author":"DA Lamprecht","year":"2016","unstructured":"Lamprecht, D. A. et al. Turning the respiratory flexibility of Mycobacterium tuberculosis against itself. Nat. Commun. 7, 12393 (2016).","journal-title":"Nat. Commun."},{"key":"9654_CR31","doi-asserted-by":"publisher","first-page":"11945","DOI":"10.1073\/pnas.0711697105","volume":"105","author":"SP Rao","year":"2008","unstructured":"Rao, S. P., Alonso, S., Rand, L., Dick, T. & Pethe, K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 105, 11945\u201311950 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9654_CR32","doi-asserted-by":"publisher","first-page":"7326","DOI":"10.1073\/pnas.1803723115","volume":"115","author":"K Hards","year":"2018","unstructured":"Hards, K. et al. Ionophoric effects of the antitubercular drug bedaquiline. Proc. Natl. Acad. Sci. USA 115, 7326\u20137331 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9654_CR33","doi-asserted-by":"publisher","first-page":"11561","DOI":"10.1073\/pnas.1608623113","volume":"113","author":"SA Cochrane","year":"2016","unstructured":"Cochrane, S. A. et al. Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II. Proc. Natl. Acad. Sci. USA 113, 11561\u201311566 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9654_CR34","doi-asserted-by":"publisher","first-page":"25273","DOI":"10.1074\/jbc.M803899200","volume":"283","author":"A Koul","year":"2008","unstructured":"Koul, A. et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis.  J. Biol. Chem. 283, 25273\u201325280 (2008).","journal-title":"J. Biol. Chem."},{"key":"9654_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00272-17","author":"D Bald","year":"2017","unstructured":"Bald, D., Villellas, C., Lu, P. & Koul, A. Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery. mBio https:\/\/doi.org\/10.1128\/mBio.00272-17 (2017).","journal-title":"mBio"},{"key":"9654_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2958.2009.06625.x","volume":"72","author":"RK Dhiman","year":"2009","unstructured":"Dhiman, R. K. et al. Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence. Mol. Microbiol. 72, 85\u201397 (2009).","journal-title":"Mol. Microbiol."},{"key":"9654_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ijbiomac.2022.05.124","volume":"212","author":"P Anand","year":"2022","unstructured":"Anand, P. & Akhter, Y. A review on enzyme complexes of electron transport chain from Mycobacterium tuberculosis as promising drug targets. Int. J. Biol. Macromol. 212, 474\u2013494 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"9654_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2017.11.001","volume":"36","author":"K Hards","year":"2018","unstructured":"Hards, K. & Cook, G. M. Targeting bacterial energetics to produce new antimicrobials. Drug Resist. Updat. 36, 1\u201312 (2018).","journal-title":"Drug Resist. Updat."},{"key":"9654_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.5858\/2005-129-1295-DOMRDI","volume":"129","author":"KK Abu-Amero","year":"2005","unstructured":"Abu-Amero, K. K. & Bosley, T. M. Detection of mitochondrial respiratory dysfunction in circulating lymphocytes using resazurin. Arch. Pathol. Lab. Med. 129, 1295\u20131298 (2005).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"9654_CR40","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","volume":"130","author":"MA Kohanski","year":"2007","unstructured":"Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797\u2013810 (2007).","journal-title":"Cell"},{"key":"9654_CR41","doi-asserted-by":"publisher","first-page":"E2100","DOI":"10.1073\/pnas.1401876111","volume":"111","author":"DJ Dwyer","year":"2014","unstructured":"Dwyer, D. J. et al. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc. Natl. Acad. Sci. USA 111, E2100\u2013E2109 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9654_CR42","doi-asserted-by":"publisher","first-page":"18867","DOI":"10.1074\/jbc.M116.739227","volume":"291","author":"AE Grzegorzewicz","year":"2016","unstructured":"Grzegorzewicz, A. E. et al. Assembling of the Mycobacterium tuberculosis cell wall core.  J. Biol. Chem. 291, 18867\u201318879 (2016).","journal-title":"J. Biol. Chem."},{"key":"9654_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"9654_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1039\/D1NP00011J","volume":"39","author":"J Han","year":"2022","unstructured":"Han, J., Liu, X., Zhang, L., Quinn, R. J. & Feng, Y. Anti-mycobacterial natural products and mechanisms of action. Nat. Prod. Rep. 39, 77\u201389 (2022).","journal-title":"Nat. Prod. Rep."},{"key":"9654_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.chembiol.2010.09.009","volume":"17","author":"PA Smith","year":"2010","unstructured":"Smith, P. A., Roberts, T. C. & Romesberg, F. E. Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations. Chem. Biol. 17, 1223\u20131231 (2010).","journal-title":"Chem. Biol."},{"key":"9654_CR46","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1128\/AAC.02293-13","volume":"58","author":"PA Black","year":"2014","unstructured":"Black, P. A. et al. Energy metabolism and drug efflux in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58, 2491\u20132503 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9654_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/mr.60.4.575-608.1996","volume":"60","author":"IT Paulsen","year":"1996","unstructured":"Paulsen, I. T., Brown, M. H. & Skurray, R. A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60, 575\u2013608 (1996).","journal-title":"Microbiol. Rev."},{"key":"9654_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0014-5793(03)01085-8","volume":"555","author":"G Chang","year":"2003","unstructured":"Chang, G. Multidrug resistance ABC transporters. FEBS Lett. 555, 102\u2013105 (2003).","journal-title":"FEBS Lett."},{"key":"9654_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4369","volume":"5","author":"A Koul","year":"2014","unstructured":"Koul, A. et al. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nat. Commun. 5, 3369 (2014).","journal-title":"Nat. Commun."},{"key":"9654_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrmicro2474","volume":"9","author":"JG Hurdle","year":"2011","unstructured":"Hurdle, J. G., O\u2019Neill, A. J., Chopra, I. & Lee, R. E. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9, 62\u201375 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"9654_CR51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41423-020-0502-z","volume":"17","author":"Q Chai","year":"2020","unstructured":"Chai, Q., Wang, L., Liu, C. H. & Ge, B. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis. Cell. Mol. Immunol. 17, 901\u2013913 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"9654_CR52","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1038\/emboj.2011.358","volume":"30","author":"Y Kawai","year":"2011","unstructured":"Kawai, Y. et al. A widespread family of bacterial cell wall assembly proteins.  EMBO J. 30, 4931\u20134941 (2011).","journal-title":"EMBO J."},{"key":"9654_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-617","volume":"9","author":"J H\u00fcbscher","year":"2008","unstructured":"H\u00fcbscher, J., L\u00fcthy, L., Berger-B\u00e4chi, B. & Stutzmann Meier, P. Phylogenetic distribution and membrane topology of the LytR-CpsA-Psr protein family. BMC Genomics 9, 617 (2008).","journal-title":"BMC Genomics"},{"key":"9654_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00972-16","author":"J Harrison","year":"2016","unstructured":"Harrison, J. et al. Lcp1 is a phosphotransferase responsible for ligating arabinogalactan to peptidoglycan in Mycobacterium tuberculosis. mBio https:\/\/doi.org\/10.1128\/mBio.00972-16 (2016).","journal-title":"mBio"},{"key":"9654_CR55","doi-asserted-by":"publisher","first-page":"E8711","DOI":"10.1073\/pnas.1707792114","volume":"114","author":"S K\u00f6ster","year":"2017","unstructured":"K\u00f6ster, S. et al. Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA. Proc. Natl. Acad. Sci. USA 114, E8711\u2013e8720 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9654_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22012-6","volume":"8","author":"S Malm","year":"2018","unstructured":"Malm, S., Maa\u00df, S., Schaible, U. E., Ehlers, S. & Niemann, S. In vivo virulence of Mycobacterium tuberculosis depends on a single homologue of the LytR-CpsA-Psr proteins. Sci. Rep. 8, 3936 (2018).","journal-title":"Sci. Rep."},{"key":"9654_CR57","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","volume":"46","author":"JC Palomino","year":"2002","unstructured":"Palomino, J. C. et al. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46, 2720\u20132722 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9654_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them.  J. Antimicrob. Chemother. 52, 1 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"9654_CR59","doi-asserted-by":"publisher","first-page":"e1005020","DOI":"10.1371\/journal.ppat.1005020","volume":"11","author":"T Wang","year":"2015","unstructured":"Wang, T. et al. Type VI secretion system transports Zn2+ to combat multiple stresses and host immunity. PLoS Pathog. 11, e1005020 (2015).","journal-title":"PLoS Pathog."},{"key":"9654_CR60","doi-asserted-by":"publisher","first-page":"E7077","DOI":"10.1073\/pnas.1611173113","volume":"113","author":"A M\u00fcller","year":"2016","unstructured":"M\u00fcller, A. et al. Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains. Proc. Natl. Acad. Sci. USA 113, E7077\u2013e7086 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9654_CR61","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1128\/AAC.49.2.708-720.2005","volume":"49","author":"C Vilch\u00e8ze","year":"2005","unstructured":"Vilch\u00e8ze, C. et al. Altered NADH\/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob. Agents Chemother. 49, 708\u2013720 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9654_CR62","doi-asserted-by":"publisher","first-page":"e01245","DOI":"10.1128\/mBio.01245-14","volume":"5","author":"P Jain","year":"2014","unstructured":"Jain, P. et al. Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis. mBio 5, e01245\u201301214 (2014).","journal-title":"mBio"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09654-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09654-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09654-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:02:46Z","timestamp":1774310566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09654-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9654"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09654-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}